Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FOSTER Evolving Study Platform

NCT07871864 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT07871864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07871864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FOSTER Evolving Study Platform
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Phase 3
Overall status
Recruiting
Start date
October 31, 2026
Completion date
January 31, 2036
Enrollment
530 (estimated)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma, osteosarcoma in adolescents and young adults, osteosarcoma in children, osteosarcoma metastatic, pediatric osteosarcoma